Kimberly-Clark is taking Tylenol in $49 billion deal

morningbrew.com/stories/2025/11/04/kimberly-clark-is-taking-tylenol-in-usd49-billion-deal?utm_source=

Headaches be damned—Kimberly-Clark has struck a $48.7 billion deal to purchase Kenvue—the maker of Tylenol and a company spun off from Johnson & Johnson in 2023—in a takeover that would create the second-biggest proprietor of health and wellness products in the world.
Kimberly-Clark is…

This story appeared on morningbrew.com, 2025-11-04 05:03:00.
The Entire Business World on a Single Page. Free to Use →